Clinical factors associated with ultrashort length of stay in patients undergoing lower extremity bypass for peripheral arterial disease

被引:0
|
作者
Radomski, Shannon N. [1 ]
Sorber, Rebecca [2 ]
Canner, Joseph K. [3 ]
Holscher, Courtenay M. [1 ]
Weaver, M. Libby [4 ]
Hicks, Caitlin W. [1 ,3 ]
Reifsnyder, Thomas [1 ]
机构
[1] Johns Hopkins Med Inst, Div Vasc Surg & Endovascular Therapy, Halsted 658,600 N Wolfe St, Baltimore, MD 21287 USA
[2] Univ Washington, Div Vasc Surg, Seattle, WA USA
[3] Johns Hopkins Univ, Johns Hopkins Surg Ctr Outcomes Res JSCOR, Sch Med, Baltimore, MD USA
[4] Univ Virginia, Div Vasc Surg, Charlottesville, VA USA
关键词
Peripheral arterial disease (PAD); Length of stay; Lower extremity bypass surgery; Chronic limb-threatening ischemia; ENHANCED RECOVERY; RISK-FACTORS; SURGERY; CLAUDICATION; MANAGEMENT; SOCIETY;
D O I
10.1016/j.jvs.2024.04.073
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Length of stay (LOS) is a major driver of cost and resource utilization following lower extremity bypass (LEB). However, the variable comorbidity burden and mobility status of LEB patients makes implementing enhanced recovery after surgery pathways challenging. The aim of this study was to use a large national database to identify patient factors associated with ultrashort LOS among patients undergoing LEB for peripheral artery disease. Methods: All patients undergoing LEB for peripheral artery disease in the National Surgical Quality Improvement Project database from 2011 to 2018 were included. Patients were divided into two groups based on the postoperative length of stay : ultrashort (<= 2 days) and standard (>2 days). Thirty-day outcomes were compared using descriptive statistics, and multivariable logistic regression was used to identify patient factors associated with ultrashort LOS. Results: Overall, 17,510 patients were identified who underwent LEB, of which 2678 patients (15.3%) had an ultrashort postoperative LOS (mean, 1.8 days) and 14,832 (84.7%) patients had a standard LOS (mean, 7.1 days). When compared to patients with a standard LOS, patients with an ultrashort LOS were more likely to be admitted from home (95.9% vs 88.0%; P < .001), undergo elective surgery (86.1% vs 59.1%; P < .001), and be active smokers (52.1% vs 40.4%; P < .001). Patients with an ultrashort LOS were also more likely to have claudication as the indication for LEB (53.1% vs 22.5%; P < .001), have a popliteal revascularization target rather than a tibial/pedal target (76.7% vs 55.3%; P < .001), and have a prosthetic conduit (40.0% vs 29.9%; P < .001). There was no significant difference in mortality between the two groups (1.4% vs 1.8%; P = .21); however, patients with an ultrashort LOS had a lower frequency of unplanned readmission (10.7% vs 18.8%; P < .001) and need for major reintervention (1.9% vs 5.6%; P < .001). On multivariable analysis, elective status (odds ratio , 2.66; 95% confidence interval [CI], 2.33-3.04), active smoking (OR, 1.18; 95% CI, 1.07-1.30), and lack of vein harvest (OR, 1.55; 95% CI, 1.41-1.70) were associated with ultrashort LOS. Presence of rest pain (OR, 0.57; 95% CI, 0.51-0.63), tissue loss (OR, 0.30; 95% CI, 0.27-0.34), and totally dependent functional status (OR, 0.54; 95% CI, 0.35-0.84) were associated negatively with an ultrashort LOS. When examining the subgroup of patients who underwent vein harvest, totally dependent (OR, 0.38; 95% CI, 0.19-0.75) and partially dependent (OR, 0.53; 95% CI, 0.32-0.88) functional status were persistently negatively associated with ultrashort LOS. Conclusions: Ultrashort LOS (<= 2 days) after LEB is uncommon but feasible in select patients. Preoperative functional status and mobility are important factors to consider when identifying LEB patients who may be candidates for early discharge.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Impact of polypharmacy on patients undergoing revascularisation for peripheral arterial disease
    Franke, Philipp
    Katsogridakis, Emmanuel
    Bisdas, Theodosios
    Saratzis, Athanasios
    Torsello, Giovanni
    Tsilimparis, Nikolaos
    Stavroulakis, Konstantinos
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2025, 54 (01) : 35 - 42
  • [42] Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication
    McDermott, Mary M.
    Guralnik, Jack M.
    Ferrucci, Luigi
    Tian, Lu
    Liu, Kiang
    Liao, Yihua
    Green, David
    Sufit, Robert
    Hoff, Frederick
    Nishida, Takashi
    Sharma, Leena
    Pearce, William H.
    Schneider, Joseph R.
    Criqui, Michael H.
    CIRCULATION, 2008, 117 (19) : 2484 - 2491
  • [43] ANGIOPLASTY, BYPASS-SURGERY, AND AMPUTATION FOR LOWER-EXTREMITY PERIPHERAL ARTERIAL-DISEASE IN MARYLAND - A CLOSER LOOK
    BECKER, GJ
    FERGUSON, JG
    BAKAL, CW
    KINNISON, ML
    MCLEAN, GK
    PENTECOST, MJ
    PERLER, MD
    VANBREDA, A
    VEITH, FJ
    RADIOLOGY, 1993, 186 (03) : 635 - 638
  • [44] Additive prognosis of clinical presentation in revascularized peripheral arterial disease patients
    Garagoli, Fernando
    Chiabrando, Juan G.
    Foscolo, Maria M. Abraham
    Corna, Giuliana
    Fleitas, Maria M.
    Raleigh, Juan Valle
    De Chazal, Horacio Medina
    Chas, Jose G.
    Berrocal, Daniel H.
    Rabellino, Jose M.
    Bluro, Ignacio M.
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2022, 70 (04) : 413 - 420
  • [45] Association between homocysteine level and length of stay in patients with lower extremity atherosclerotic disease: a retrospective cohort study
    Wang, Xue
    Yang, Yu
    Xu, Li
    Yu, Ling
    Zang, Shuang
    Li, Xuan
    BMJ OPEN, 2023, 13 (07):
  • [46] Association between fibrinogen level and length of stay in patients with lower extremity atherosclerotic disease: a retrospective cohort study
    Wang, Xue
    Yang, Yu
    Yu, Ling
    Pang, Chang
    Sun, Wei
    Zang, Shuang
    Li, Cong
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [47] Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease
    Lo, Ruby C.
    Bensley, Rodney P.
    Dahlberg, Suzanne E.
    Matyal, Robina
    Hamdan, Allen D.
    Wyers, Mark
    Chaikof, Elliot L.
    Schermerhorn, Marc L.
    JOURNAL OF VASCULAR SURGERY, 2014, 59 (02) : 409 - +
  • [48] An interpretable machine learning model for the prevention of contrast-induced nephropathy in patients undergoing lower extremity endovascular interventions for peripheral arterial disease
    Cox, Meredith
    Panagides, J. C.
    Di Capua, John
    Dua, Anahita
    Kalva, Sanjeeva
    Kalpathy-Cramer, Jayashree
    Daye, Dania
    CLINICAL IMAGING, 2023, 101 : 1 - 7
  • [49] Factors Associated to Arterial Stiffness in Patients With Symptomatic Peripheral Artery Disease
    Germano-Soares, Antonio Henrique
    Farah, Breno Quintella
    Andrade-Lima, Aluisio
    Domingues, Wagner Ribeiro
    Cavalcante, Bruno Remigio
    Correia, Marilia de Almeida
    Wolosker, Nelson
    Cucato, Gabriel Grizzo
    Ritti-Dias, Raphael Mendes
    ANNALS OF VASCULAR SURGERY, 2019, 61 : 78 - 82
  • [50] Clinical impact of the infrapatellar location in symptomatic peripheral arterial disease patients
    Chiabrando, Juan G.
    Garagoli, Fernando D.
    Abraham-Foscolo, Maria M.
    Corna, Giuliana
    de-los-Milagros-Fleitas, Maria
    Valle-Raleigh, Juan
    Medina-de-Chazal, Horacio A.
    Berrocal, Daniel H.
    Rabellino, Jose M.
    Bluro, Ignacio M.
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2023, 93 (03): : 318 - 327